Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
U.S. Stock Insider Trading | VeraDermics disclosed details of one insider transaction on February 27
On February 27, 2026, VeraDermics (MANE) disclosed 1 company insider transaction. Director CHILDS JOHN W purchased 294.1k shares on February 5, 2026.
[Recent Insider Trading]
[Company Profile]
VeraDermics, Incorporated was founded on October 5, 2019. It was initially based in Texas and later converted to a Delaware corporation on September 15, 2021. This late-stage clinical-stage biopharmaceutical company, founded by dermatologists, focuses on developing innovative therapies for widely prevalent aesthetic and dermatologic conditions. VeraDermics primarily works to address the treatment challenges of pattern hair loss (PHL), which affects numerous individuals in the United States. The company is currently advancing its lead candidate drug VDPHL01, an oral non-hormonal treatment intended to optimize hair growth while minimizing side effects associated with conventional therapies. VeraDermics is conducting pivotal clinical trials to support regulatory approval, and aims to change the way PHL is managed through its targeted treatment approach.